Status:
COMPLETED
Effects of a Portfolio Diet on NAFLD in Type 2 Diabetic Patients
Lead Sponsor:
Federico II University
Conditions:
Diabetes Type 2
NAFLD
Eligibility:
All Genders
35-75 years
Phase:
NA
Brief Summary
Patients with type 2 diabetes and non-alcoholic fatty liver disease will be enrolled. According to a parallel design, the participants will be randomized to a Portfolio diet or a monounsaturated fatt...
Eligibility Criteria
Inclusion
- type 2 diabetes
- non-alcoholic fatty liver disease (evaluated by US)
- HbA1c \<7.5%
- LDL cholesterol \<130 mg/dl
Exclusion
- hypoglycemic therapy with sodium-glucose cotransporter (SGLT-2), pioglitazone and glucagon-like peptide (GLP-1) analogues
- severe liver and kidney failure
- recent cardiovascular events (prior 6 months)
- any other acute/chronic disease (anemia, cancer, BPCO)
Key Trial Info
Start Date :
April 4 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2019
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT03380416
Start Date
April 4 2017
End Date
December 20 2019
Last Update
March 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Clinical Medicine and Surgery
Naples, Italy, 80131